Genmab US, Inc.
Time frame: 1 April 2023 - 31 March 2024Article ‘Count’ and ‘Share’ for Genmab US, Inc. based on listed parameters only.
The articles listed below published by authors from Genmab US, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Pathology |
1 | 0.17 |
Journal of Clinical Oncology |
1 | 0.06 |
![Creative Commons License](https://i.creativecommons.org/l/by-nc-sa/4.0/80x15.png)
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.